No Association Between Outcomes And Anti-Factor Xa Levels For Heparin Monitoring In Patients With Cerebral Venous Thrombosis

被引：0
|
作者：
Pirahanchi, Yasaman
Salottolo, Kristin
Burrell, Christian
DiSalvo, Lauren
Tang, Xu
Bar-Or, David
Bartt, Russell
机构：
来源：
STROKE | 2023年 / 54卷
关键词：
D O I：
10.1161/str.54.suppl_1.TP12
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ATP12
引用
收藏
页数：2
相关论文
共 50 条
  • [1] No Association Between Outcomes And Anti-Factor Xa Levels For Heparin Monitoring In Patients With Cerebral Venous Thrombosis
    Pirahanchi, Yasaman
    Salottolo, Kristin
    Burrell, Christian
    Tang, Xu
    DiSalvo, Lauren
    Bar-Or, David
    Bartt, Russell
    [J]. NEUROLOGY, 2023, 100 (17)
  • [2] Pilot study examining anti-factor Xa levels for heparin monitoring and outcomes in patients with cerebral venous thrombosis
    Pirahanchi, Yasaman
    Salottolo, Kristin
    Burrell, Christian
    Tang, Xu
    Bar-Or, David
    Bartt, Russell
    [J]. FRONTIERS IN MEDICINE, 2024, 11
  • [3] Design and Implementation of an Anti-Factor Xa Heparin Monitoring Protocol
    Williams-Norwood, Tanya
    Caswell, Megan
    Milner, Barbara
    Vescera, Joseph C.
    Prymicz, Kelly
    Ciszak, Amy G.
    Ingle, Carol
    Lacey, Christopher
    Stavrou, Evi X.
    [J]. AACN ADVANCED CRITICAL CARE, 2020, 31 (02) : 129 - 137
  • [4] Comparing Anti-Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly W.
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (08) : 801 - 805
  • [5] Validation of a weight based heparin nomogram that utilizes anti-factor Xa levels for monitoring.
    Huh, Jin-Hyeun
    Leong, Derek
    Lau, Maxine
    Gavrilovic, Maja
    [J]. BLOOD, 2006, 108 (11) : 108B - 108B
  • [6] Comparing anti-factor Xa and activated partial thromboplastin levels for monitoring unfractionated heparin.
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly
    [J]. PHARMACOTHERAPY, 2018, 38 (07): : E54 - E54
  • [7] Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort
    Saini, Surbhi
    Folta, Ashley N.
    Harsh, Katherine L.
    Stanek, Joseph R.
    Dunn, Amy L.
    O'Brien, Sarah H.
    Kumar, Riten
    [J]. JOURNAL OF PEDIATRICS, 2019, 209 : 212 - +
  • [8] Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti-factor Xa levels
    Schechter, T.
    Finkelstein, Y.
    Ali, M.
    Kahr, W. H.
    Williams, S.
    Chan, A. K.
    Deveber, G.
    Brandao, L. R.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (03) : 368 - 374
  • [9] Synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities
    Xu, Yongmei
    Stancanelli, Eduardo
    Su, Guowei
    Liu, Jian
    [J]. GLYCOBIOLOGY, 2023, 33 (11) : 1057 - 1057
  • [10] IMPACT OF TARGETED TEMPERATURE MANAGEMENT ON ANTI-FACTOR XA MONITORING OF UNFRACTIONATED HEPARIN
    Fedkiv, Volodymyra
    Oh, Song
    Bingham, Angela
    Delic, Justin
    Igneri, Lauren
    Hollands, James
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 596 - 596
12345